Lichen International Limited LICN
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $24.52M · Filed Apr 28, 2026
Lichen International Limited (LICN) files with the SEC under industry code 8742, Services-Management Consulting Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $24.5 million and a net loss of $22.0 million. Free cash flow was -$17.8 million. As of Dec 31, 2025 it held $28.6 million in cash and investments and $554,000 in total debt.
Revenue
$24.52M
Net income
$-21.96M
-257.7% vs prior year
Operating cash flow
$-17.85M
-220.3% vs prior year
Free cash flow
$-17.85M
-218.3% vs prior year
EPS
$-4.11
+88.2% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$28.08M
FY 2025
Operating margin
-73.7%
FY 2025
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- LICN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Jinjiang City, Fujian Province, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1876766
- Former names
- Lichen China Ltd (until Feb 28, 2025)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- Astrana Health, Inc. ASTH
- ICF International, Inc. ICFI
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $24.5M | $0 | $39.8M | $33.8M |
| Operating income | -$18.1M | -$4.6M | $12.3M | $10.6M |
| Net income | -$22.0M | -$6.1M | $8.3M | $7.8M |
| Diluted EPS | -$4.11 | -$34.79 | $63.96 | $69.50 |
| Operating cash flow | -$17.8M | -$5.6M | $557,000 | $10.8M |
| Free cash flow | -$17.8M | -$5.6M | -$2.6M | — |
| Total assets | $75.6M | $79.8M | $65.5M | $46.5M |
| Total liabilities | $5.0M | $4.3M | $4.1M | $5.4M |
| Stockholders' equity | $70.5M | $73.2M | $61.4M | $41.1M |
| Cash and investments | $28.6M | $26.9M | $25.9M | $22.6M |
| Total debt | $554,000 | $61,000 | $1.7M | $272,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 23, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K/A | Form 6-k/a | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Jun 30, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 28, 2026 | Dec 31, 2025 |
All 110 Lichen International Limited SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.